[HTML][HTML] Phosphatidylserine targeting for diagnosis and treatment of human diseases

K Schutters, C Reutelingsperger - Apoptosis, 2010 - Springer
Cells are able to execute apoptosis by activating series of specific biochemical reactions.
One of the most prominent characteristics of cell death is the externalization of …

Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development

T Quillard, P Libby - Circulation research, 2012 - Am Heart Assoc
Despite recent progress, cardiovascular and allied metabolic disorders remain a worldwide
health challenge. We must identify new targets for therapy, develop new agents for clinical …

Optical and magnetic resonance imaging of cell death and platelet activation using annexin A5-functionalized quantum dots

L Prinzen, RJJHM Miserus, A Dirksen, TM Hackeng… - Nano …, 2007 - ACS Publications
A quantum-dot-based nanoparticle is presented, allowing visualization of cell death and
activated platelets with fluorescence imaging and MRI. The particle exhibits intense …

Imaging atherosclerosis and vulnerable plaque

MM Sadeghi, DK Glover, GM Lanza… - Journal of Nuclear …, 2010 - Soc Nuclear Med
Identifying patients at high risk for an acute cardiovascular event such as myocardial
infarction or stroke and assessing the total atherosclerotic burden are clinically important …

[HTML][HTML] Molecular imaging of inflammation in atherosclerosis

M Wildgruber, FK Swirski, A Zernecke - Theranostics, 2013 - ncbi.nlm.nih.gov
Acute rupture of vulnerable plaques frequently leads to myocardial infarction and stroke.
Within the last decades, several cellular and molecular players have been identified that …

[HTML][HTML] New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease

OO Sogbein, M Pelletier-Galarneau… - BioMed research …, 2014 - hindawi.com
Nuclear cardiology has experienced exponential growth within the past four decades with
converging capacity to diagnose and influence management of a variety of cardiovascular …

Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques

M Ogawa, Y Magata, T Kato, K Hatano… - Journal of Nuclear …, 2006 - Soc Nuclear Med
The rupture of atherosclerotic vulnerable plaques and subsequent formation of thrombi are
the main factors responsible for myocardial and cerebral infarctions. Because macrophage …

Lantibiotics as probes for phosphatidylethanolamine

M Zhao - Amino acids, 2011 - Springer
Phosphatidylethanolamine (PE) is a major component in the mammalian plasma
membrane. It is present mainly in the inner leaflet of the membrane bilayer in a viable …

Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent

R Bhavane, C Badea, KB Ghaghada… - Circulation …, 2013 - Am Heart Assoc
Background—The accumulation of macrophages in inflamed atherosclerotic plaques has
long been recognized. In an attempt to develop an imaging agent for detection of vulnerable …

Targeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti–LOX-1 antibody: potential agent for imaging of vulnerable plaque

S Ishino, T Mukai, Y Kuge, N Kume… - Journal of Nuclear …, 2008 - Soc Nuclear Med
Lectinlike oxidized low-density lipoprotein (LDL) receptor 1 (LOX-1), a cell surface receptor
for oxidized LDL, has been implicated in vascular cell dysfunction related to plaque …